Lundbeck and Otsuka’s Rexulti has become the first drug ... anxiety medicines and antidepressants, which are already being used off-label to treat Alzheimer’s associated dementia.

making it the first drug to treat agitation symptoms in dementia patients. Some prior attempts — such as by Otsuka and BioXcel Therapeutics — to develop an Alzheimer's-related agitation ...

Further research is needed to identify which strategies are most effective in managing symptoms of agitation associated with the different types of dementia ... side effects, drug-drug ...

Dec 30 (Reuters) - Axsome Therapeutics (AXSM.O), opens new tab said on Monday it would seek marketing approval next year for its oral drug to treat agitation in patients with Alzheimer's disease ...

Axsome Therapeutics (NASDAQ:AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05, or dextromethorphan-bupropion, in the treatment of agitation in ...